Power Law company profile

Pendulum Therapeutics

Biotech & Life Sciences · San Francisco, United States · Founded 2012 Colt

Microbiome company focused on enabling better patient care through targeted equilibration of human microbiomes

Valuation

$100–500M

Latest valuation · 2026

Unlock exact value

Revenue

$10–50M

Latest reported FY

Unlock exact value

Headcount

100–500

Current team size

Unlock exact value

Featured in $1B+ revenueColt · Power Law growth-stage

Investors

7 investors on Pendulum Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage

Mercuri

Series B+ 6 investors entered at this stage

True Ventures

Nutrition Science Solutions

Sequoia

Mayo Clinic

Khosla Ventures

AME Cloud Ventures

Global footprint

Where Pendulum Therapeutics has talent and traffic

AI talent share

4.3% of workforce is AI talent
(5 of 115 staff)

Core AI10.87%

Other AI43.48%

Non-AI workforce11095.65%

Workforce by country

🇺🇸 United States · San Francisco HQ

Book a demo for the full country breakdown

Market sentiment

What the market is saying about Pendulum Therapeutics

An AI-synthesized read of the highest-engagement posts about Pendulum Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Pendulum Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles